In one small observational study examining plasma NGAL and IL-9 as predictors of postoperative AKI in 21 coronary artery bypass patients undergoing CPB, neither biomarker achieved statistical significance as an independent predictor, suggesting limited usefulness of IL-9 in other clinical context [111]. The gene discussed is LCN2; the disease is acute kidney injury.